PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16129039-3	2005	The results showed at follows: (1) the level of IRP(2) mRNA remained constant in all cells, whether or not treated with DFO or FeCl(3).	Deferoxamine	120-123	iron responsive element binding protein 2	Homo sapiens	48-54	
12888568-2	2003	Iron regulates IRP2 by mediating its rapid proteasomal degradation, where hypoxia and the hypoxia mimetics CoCl2 and desferrioxamine (DFO) stabilize it.	Deferoxamine	117-132	iron responsive element binding protein 2	Homo sapiens	15-19	
12888568-2	2003	Iron regulates IRP2 by mediating its rapid proteasomal degradation, where hypoxia and the hypoxia mimetics CoCl2 and desferrioxamine (DFO) stabilize it.	Deferoxamine	134-137	iron responsive element binding protein 2	Homo sapiens	15-19	
12888568-5	2003	In addition, DFO and hypoxia blocked the degradation of both the wild-type and mutant IRP2 proteins.	Deferoxamine	13-16	iron responsive element binding protein 2	Homo sapiens	86-90	
12888568-9	2003	In addition, hypoxia, DFO and DMOG blocked IRP2 ubiquitination.	Deferoxamine	22-25	iron responsive element binding protein 2	Homo sapiens	43-47